Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey.
Crossman AR, Peggs D, Boyce S, Luquin MR, Sambrook MA.
Crossman AR, et al. Among authors: boyce s.
Neuropharmacology. 1989 Nov;28(11):1271-3. doi: 10.1016/0028-3908(89)90221-9.
Neuropharmacology. 1989.
PMID: 2687716
The administration of the selective neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to produce a primate model of Parkinson's disease is well-documented (Burns, Markey, Phillips & Chiuch, 1984; Crossman, 1987; Langston, Forno, Rebert & Irwin, 1984). …
The administration of the selective neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to produce a primate model of Parkinson' …